W Döll
Impact in
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
-
- HIV Research and Treatment
Papers in
-
- Drug Solubulity and Delivery Systems 5
-
- Protein purification and stability 2
- Co-authors
- Erik P. Sandefer (14 shared papers)Richard C. Page (12 shared papers)George A. Digenis (7 shared papers)Giancarlo Santus (1 shared paper)U. Yun Ryo (1 shared paper)Sean N. Tucker (1 shared paper)James Ermer (2 shared papers)Leesun Kim (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (2 papers)Pharmaceutical Research (2 papers)Scientific Reports (1 paper)International Journal of Pharmaceutics (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
W Döll
21 papers receiving 341 citations
Peers
Comparison fields: 5 of 86
- Pharmaceutical Science 167
- Virology 32
- Infectious Diseases 75
- Gastroenterology 22
- Analytical Chemistry 32
Countries citing papers authored by W Döll
This map shows the geographic impact of W Döll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Döll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Döll more than expected).
Fields of papers citing papers by W Döll
This network shows the impact of papers produced by W Döll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Döll. The network helps show where W Döll may publish in the future.
Co-authors
The 25 scholars most cited alongside W Döll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 67 | |
| 2 | 2013 | 44 | |
| 3 | 2016 | 41 | |
| 4 | 2000 | 32 | |
| 5 | 2011 | 31 | |
| 6 | 2007 | 25 | |
| 7 | 1998 | 24 | |
| 8 | 2008 | 20 | |
| 9 | 2011 | 18 | |
| 10 | 1995 | 15 | |
| 11 | 2002 | 11 | |
| 12 | 1998 | 9 | |
| 13 | 2020 | 9 | |
| 14 | [Treatment of botulism with guanidine]. | 1970 | 8 |
| 15 | 1971 | 6 | |
| 16 | 2012 | 6 | |
| 17 | [The effect of the pipe material of the drinking water system on the frequency of Legionella in a hospital]. | 1994 | 4 |
| 18 | 1956 | 2 | |
| 19 | 2024 | 1 | |
| 20 | [Interference of interfacial compounds with bacteriological & serological test procedures]. | 1958 | 1 |
About W Döll
W Döll is a scholar working on Pharmaceutical Science, Molecular Biology, Pulmonary and Respiratory Medicine, Gastroenterology and Surgery, having authored 27 papers that have together received 377 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (5 papers), Gastroesophageal reflux and treatments (3 papers), Gastrointestinal motility and disorders (2 papers), Pharmaceutical studies and practices (2 papers), Inhalation and Respiratory Drug Delivery (2 papers), Attention Deficit Hyperactivity Disorder (2 papers), Amino Acid Enzymes and Metabolism (2 papers) and Protein purification and stability (2 papers). The work is most often cited by research in Pharmaceutical Science (167 citations), Virology (32 citations), Infectious Diseases (75 citations), Gastroenterology (22 citations) and Analytical Chemistry (32 citations). W Döll has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Erik P. Sandefer, Richard C. Page, George A. Digenis, Giancarlo Santus, U. Yun Ryo, Sean N. Tucker, James Ermer, Leesun Kim, T. Gold and Li Zhu. Their work appears in journals such as Journal of Pharmaceutical Sciences, Pharmaceutical Research, Scientific Reports, International Journal of Pharmaceutics and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.